NOW vs RXRX · P/E 69, rev $13.28B vs rev $58.8M
ServiceNow Inc (NOW) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
ServiceNow Inc (NOW) is a software - application company listed on US. It is led by Bill McDermott.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported NOW revenue for 2025-12-31 was $13.28B. Net income was $1.75B. Revenue was up 20.9% from 2024-12-31 to 2025-12-31. NOW currently screens at market cap $119.00B and trailing P/E 68.7.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
NOW currently screens at market cap $119.00B and trailing P/E 68.7. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the NOW and RXRX stock pages for the full models.
Not investment advice.